e-learning
resources
Berlin 2001
Tuesday 25.09.2001
Therapy for non-small cell lung cancer
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
High dose rate endobronchial brachytherapy in the palliative management of bronchial cancer - comparison of different doses
J. Skowronek, T. Piorunek, S. Cofta, K. Swierkocki, W. Mlynarczyk (Poznan, Poland)
Source:
Annual Congress 2001 - Therapy for non-small cell lung cancer
Session:
Therapy for non-small cell lung cancer
Session type:
Poster Discussion
Number:
2571
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
J. Skowronek, T. Piorunek, S. Cofta, K. Swierkocki, W. Mlynarczyk (Poznan, Poland). High dose rate endobronchial brachytherapy in the palliative management of bronchial cancer - comparison of different doses. Eur Respir J 2001; 16: Suppl. 31, 2571
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Efficacy of Breathox® device inhalation on acute symptoms associated with COVID-19 (BREATH study)
A 12-year-old male child with fever, productive cough and sudden onset paralysis
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
HDR endobronchial brachytherapy (HDR-BT) in the management of advanced lung cancer – comparison of different protocols
Source: Annual Congress 2008 - Lung cancer and other malignant diseases involving the lungs
Year: 2008
Prodromal face of a study: High dose rate endobronchial brachytherapy (HDERB) as a first step introductory treatment of a multimodality therapy approach in non operable NSCLC with endobronchial obstruction
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Endobronchial brachytherapy in the treatment of malignant lung tumours
Source: Eur Respir J 2004; 24: 348-352
Year: 2004
Cryotherapy plus chemotherapy or radiation offers increased survival and quality of life in advanced stage lung cancer patients with endobronchial obstruction: Analysis of 160 patients treated with the rigid bronchoscope
Source: Annual Congress 2012 - Mediastinum and tracheobronchial tree
Year: 2012
External irradiation
versus
external irradiation plus endobronchial brachytherapy in inoperable non small cell lung cancer
Source: Annual Congress 2007 - Therapeutic approaches in thoracic oncology
Year: 2007
Improved results after preoperative concurrent chemotherapy and high dose radiation therapy in selected cases with stage III N2 lung cancer?
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Bronchoscopic high-dose-rate brachytherapy
Source: Eur Respir Mon; 2010: 48: 173–189
Year: 2010
Palliative treatment of locally advanced non small cell lung cancer with weekly fraction radiotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 496s
Year: 2005
A new treatment strategy for stage III lung cancer presenting with airway obstruction: neoadjuvant endobronchial intratumoral chemotherapy (EITC)
Source: Annual Congress 2009 - Biopsy techniques
Year: 2009
Symptomatic benefit of short regimen of palliative radiotherapy for elderly patients with locally advanced non small cell lung cancer
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010
Estimation of the mediastinal involvement probability in lung cancer: a statistical definition of the clinical target volume for 3-dimensional conformal radiotherapy?
Source: Eur Respir J 2002; 20: Suppl. 38, 186s
Year: 2002
Results of low dose iridium 192 brachytherapy in malignant airway stenosis
Source: Eur Respir J 2001; 18: Suppl. 33, 375s
Year: 2001
Hypofractionated radiotherapy for stage I lung carcinomas: moderate hypofractionation optimizes outcome
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018
Combined radiation therapy in treatment of tracheal cancers
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008
The rate of curative intended therapy against recurrent lung cancer before and after introduction of a CT-based follow-up program
Source: Annual Congress 2013 –Quality management in thoracic oncology
Year: 2013
Optimisation of bronchial brachytherapy catheter placement with a modified airway stent
Source: Eur Respir J 2008; 31: 902-903
Year: 2008
Electromagnetically navigated bronchoscopy and endobronchial ultrasound for brachytherapy of inoperable peripheral lung cancer – a prospective feasibility and safety study
Source: Annual Congress 2007 - Bronchoscopic staging modalities in lung cancer
Year: 2007
Influence of dose of radiotherapy on quality of life in patients with non-small cell lung cancer treated by radiotherapy
Source: Eur Respir J 2005; 26: Suppl. 49, 495s
Year: 2005
Measurement of individual quality of life in patients with lung cancer receiving palliative chemotherapy
Source: Eur Respir J 2003; 22: Suppl. 45, 432s
Year: 2003
A single center experience with lung volume reduction coil (LVR-coil) treatment of patients with advanced emphysema. Effectiveness and complications after 1 year
Source: International Congress 2016 – Endoscopic lung volume reduction II
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept